SEC Form 3 · accession 0001615774-15-000675

Enumeral Biomedical Holdings, Inc. · ENUM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Apr 3, 2015

Accepted (ET)

Apr 3, 2015 · 4:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001561551

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	7,966,368	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)	$1.00	holding	—	—	—	Aug 4, 2014	Aug 3, 2024	Common Stock	20,000	—	I
Stock Option (Right to Buy)^F1	$1.00	holding	—	—	—	—	Aug 3, 2024	Common Stock	60,000	—	I
Common Stock Purchase Warrant^F2	$0.2451	holding	—	—	—	Jul 31, 2014	Feb 2, 2024	Common Stock	255,120	—	D
Common Stock Purchase Warrant	$2.00	holding	—	—	—	Jul 31, 2014	Jul 30, 2019	Common Stock	1,500,000	—	D

F1The option vests and becomes exercisable as follows: (a) 36,667 shares were vested as of August 4, 2014, and (b) 23,333 will vest in 14 equal monthly installments through October 1, 2015. The option has been issued to Daniel Wolfe, a director of the Issuer. Mr. Wolfe has assigned the economic benefit of the option to the reporting person.
F2Represents a warrant issued to the reporting person in exchange for a warrant previously issued by Enumeral Biomedical Corp. (the "Predecessor") pursuant to the terms of the merger of the Predecessor with a wholly-owned subsidiary of the Issuer.